Skip to content
Open access

Comparison of rocuronium‑sugammadex and mivacurium on recovery efficiency after pediatric isolated adenoidectomy: a propensity score‑matched cohort study

Oct 2026 · BMC Anesthesiology · 0 citations

TL;DR

In children undergoing isolated adenoidectomy, the rocuronium-sugammadex regimen was associated with modestly shorter extubation time in primary analysis, though this finding was not confirmed in paired sensitivity analysis, together with significantly reduced PACU discharge time and delayed discharge risk, without compromising postoperative recovery safety or comfort.

Abstract

Mivacurium and rocuronium-sugammadex are two commonly used neuromuscular blocking regimens in pediatric otorhinolaryngological surgery. However, existing comparative studies frequently combine isolated adenoidectomy with adenotonsillectomy, introducing significant confounding variables; consequently, dedicated head-to-head comparisons restricted to isolated adenoidectomy remain scarce. This study aimed to compare postoperative recovery efficiency between rocuronium-sugammadex reversal and mivacurium monotherapy, two routinely used clinical regimens, in children aged 3–12 years undergoing isolated adenoidectomy. Of 877 eligible children, 616 children (308 matched pairs) were analyzed after 1:1 propensity-score matching. The primary endpoint was the time from cessation of anesthetic maintenance agents to tracheal extubation. Secondary endpoints included time from anesthetic cessation to post-anaesthesia care unit (PACU) discharge, emergence quality, and postoperative pain scores. The median time from anesthetic discontinuation to extubation was 23 min in the rocuronium-sugammadex group versus 25 min in the mivacurium group Hodges-Lehmann (HL) pseudomedian difference − 2 min; (95% CI − 4.00 to − 0.0001; P  = 0.022). However, this modest between-group difference was not statistically significant in a paired sensitivity analysis ( P  = 0.069). The median interval from drug cessation to PACU discharge was shorter in the rocuronium-sugammadex group (38 [30.00–48.00] min) than in the mivacurium group (42 [34.00–51.00] min), with a HL pseudomedian difference of − 4.00 min (95% CI − 6.00 to − 2.00; P  < 0.001). Steward scores were comparable ( P  = 0.416); VAS pain scores differed statistically ( P  = 0.016) but the absolute difference was minimal. Subgroup analysis showed that shorter extubation time was observed only in children receiving intraoperative midazolam. Shorter PACU discharge duration was also seen in this subgroup and in both age subgroups, but not in children without midazolam. In children undergoing isolated adenoidectomy, the rocuronium-sugammadex regimen was associated with modestly shorter extubation time in primary analysis, though this finding was not confirmed in paired sensitivity analysis, together with significantly reduced PACU discharge time and delayed discharge risk, without compromising postoperative recovery safety or comfort. Benefits in extubation time and PACU discharge duration were observed primarily in children receiving intraoperative midazolam; however, formal interaction analysis for this exploratory subgroup comparison did not demonstrate significant effect modification. Taken together, under real-world clinical dosing conditions, these findings suggest that this rocuronium-sugammadex anesthetic strategy may help optimize patient turnover in high-volume pediatric day-surgery centers.

Read PDF

Similar papers

Open access Oct 2026

Safety and recovery of rocuronium and sugammadex versus cisatracurium or atracurium and pyridostigmine in surgical patients with chronic kidney disease: a multi-center retrospective propensity score-matched study.

Background Rocuronium and sugammadex are used cautiously in patients with chronic kidney disease (CKD) undergoing anesthesia because of delayed excretion. This multicenter retrospective study explored the safety and recovery of rocuronium-sugammadex compared to cisatracurium/atracurium-pyridostigmine in patients with C...

D. Lee, S. Oh, H. Kim et al. · 0 citations
Open access Oct 2026

Sugammadex versus no pharmacological reversal under quantitative neuromuscular monitoring: a propensity score-matched analysis of postoperative pulmonary complications.

Under routine quantitative NMT, sugammadex administration was associated with more frequent achievement of a train-of-four (TOF) ratio ≥0.9 but not with lower incidences of postoperative pneumonia or secondary outcomes.

Soshi Narasaki, Yuki Ota, Hirotsugu Miyoshi et al. · 1 citation
Clinical trial Open access Oct 2026

Effect of Oliceridine on Early Postoperative Recovery in Children Undergoing Adenotonsillectomy: A Prospective, Double-Blind, Randomized Controlled Trial

Background Children undergoing adenotonsillectomy may be vulnerable to opioid-related adverse effects, creating a need for analgesic strategies that support rapid postoperative recovery. This study compared the perioperative effects of oliceridine and sufentanil in children undergoing adenotonsillectomy under general a...

Yuan Wang, Zhi-Chun Cui, Zhong-Gang Cheng et al. · 0 citations
Open access Sep 2026

End-of-Surgery Remimazolam Bolus Reduces Emergence Delirium in Children Undergoing Tonsillectomy and Adenoidectomy: A Randomized, Triple-Blind, Placebo-Controlled Trial

Background/Objectives: Emergence delirium (ED) is common after sevoflurane anesthesia in children undergoing otolaryngologic surgery. Remimazolam is an ultra-short-acting benzodiazepine that may reduce ED without delaying recovery. This study evaluated the effect of a single remimazolam bolus administered at the end of...

Grgur Prižmić, F. Periš, Anamarija Mitar et al. · 0 citations
Open access Sep 2026

Remimazolam versus sevoflurane for maintenance of anesthesia and postoperative nausea and vomiting in laparoscopic gynecologic oncology surgery: a randomized controlled trial

Remimazolam-based anesthesia was associated with a lower incidence of PONV compared with sevoflurane in patients undergoing laparoscopic gynecologic oncology surgery, and the observed reduction was slightly smaller than the effect size predefined during sample size estimation.

Chao-Peng Ou, Xuan-Wei Huang, Hong-Yun Wei et al. · 0 citations
Review Oct 2026

Remimazolam Versus Propofol for Anesthesia Induction and Maintenance in Adult Cardiac Surgical Patients: A PRISMA-Compliant Systematic Review and Meta-analysis.

OBJECTIVES To compare remimazolam-based with propofol-based anesthesia for induction and maintenance in adult cardiac surgery. DESIGN Systematic review and meta-analysis of randomized controlled trials. SETTING Cardiovascular centers. PARTICIPANTS Adults undergoing cardiac surgery. INTERVENTIONS Remimazolam-bas...

Yun-Tai Yao, Shuo Huang, Hong-Bai Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.